Rapid Improvement of Acute Pulmonary Edema with Sublingual Captopril

抄録

<jats:title>ABSTRACT</jats:title><jats:p><jats:bold>Objective:</jats:bold> To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O<jats:sub>2</jats:sub>, nitrates, morphine, and furosemide.</jats:p><jats:p><jats:bold>Methods:</jats:bold> Prospective, randomized, double‐blind, placebo‐controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually Every 5 minutes a clinical APE distress score (APEX) was obtained.</jats:p><jats:p><jats:bold>Results:</jats:bold> Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0. 001, F = 14. 5, one‐way (repeated‐measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43% (i. e., to 57% of initial distress); the group given the current standard regimen plus placebo improved only 25% (i. e., to 75% of initial distress; p = 0. 03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9%) vs the placebo patients (20%), which did not achieve significance (p = 0. 10, Fisher's exact test).</jats:p><jats:p><jats:bold>Conclusion:</jats:bold> In APE, the addition of sublingual captopril to the standard regimen of O<jats:sub>2</jats:sub>, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ